To verify the relevance of our findings in the mouse model for the disorder in humans, we examined the expression of Hebp1 and Glo1, the two most upregulated early markers, in postmortem brain samples obtained from AD patients and age-matched healthy controls (Figure 3; detailed patient information is provide in Table 2). Here, HEBP1 is linked to Alzheimer disease.